Crinetics Pharmaceuticals · 8 hours ago
Associate Director, In Vitro Pharmacology
San Diego, CA
Full-time
Onsite
Lead/Staff, Director/Executive
$160K/yr - $200K/yr
8+ years expCrinetics Pharmaceuticals is a pharmaceutical company based in San Diego, California, developing therapies for endocrine diseases and related tumors. They are seeking an Associate Director with expertise in GPCR pharmacology and drug discovery to lead in vitro pharmacology activities and support drug discovery programs.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Possess scientific leadership and hands-on management of a team of scientists in an environment that promotes collaboration, teamwork, and innovative science
Design, development, validation, and execution of in vitro assays that support drug discovery programs
Perform organizational management to deliver critical in vitro experimental data that supports multiple programs simultaneously
Possess high-level initiative to oversee, troubleshoot, and accurately perform data analysis in an environment that values scientific integrity and quality
Demonstrate functional representation and lead cross-functional Program Teams
Interpret effective written and oral communication of results to interdisciplinary teams
Participate in strategic planning of departmental growth, organization, and evaluation of new targets
Prepare technical reports to support program reviews, publications, and IND submissions
Identify and evaluate new research targets within therapeutic areas of interest
Responsible for ensuring compliance with company established practices and procedures, including laboratory notebooks, computer files, quality and regulatory guidelines, and safety standards
Other duties as assigned
Qualification
Required
Ph.D. in Pharmacology, Biochemistry, Biology, or related discipline with a minimum of 8 years of relevant experience. Applicants with BS or MS degrees must demonstrate a minimum of 10 years of significant and relevant experience
At least 7 years of experience with drug discovery and small molecule pharmacology at therapeutically relevant GPCRs or related field
Minimum supervisory experience of 7 years
Demonstrated extensive and in-depth technical proficiency in biochemical, cellular, and/or radioligand binding assay systems and ability to ensure highest quality of in vitro assay data
Ability to independently determine in vitro pharmacologic methods and procedures to achieve Program goals
Outstanding experimental design, problem-solving, and data analysis skills and the ability to independently establish in vitro pharmacologic approaches to achieve program goals
Demonstrated practical experience and deep understanding of in vitro pharmacological theory, models, mechanisms, and experimental design, particularly with GPCRs
Must be independent and able to follow pre-established experimental designs, as well as develop new methods, protocols, and technologies based on existing literature
Strong work ethic and enthusiasm for a mix of laboratory work and management in a dynamic environment
Experience in management and daily supervision of scientific staff
Experience in program management/leadership
Strong written and verbal communication skills and ability to work effectively in a multidisciplinary team environment
Experience with writing reports and technical regulatory documents
Must be detail-oriented, punctual, and reliable
Ability to work in a fast-paced environment and adapt to change
Benefits
Discretionary annual target bonus
Stock options
ESPP
401k match
Top-notch health insurance plans for employees (and their families) to include medical, dental, vision and basic life insurance
20 days of PTO
10 paid holidays
Winter company shutdown
Company
Crinetics Pharmaceuticals
Crinetics is a clinical-stage pharmaceutical company that develops therapies for people with rare endocrine diseases.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$2BKey Investors
Frazier Healthcare PartnersNational Institutes of HealthPerceptive Advisors
2026-01-06Post Ipo Equity· $349.22M
2024-10-08Post Ipo Equity· $500M
2024-02-28Post Ipo Equity· $350M
Leadership Team
R. Scott Struthers
Founder, CEO
A
Alan S. Krasner
Chief Endocrinologist
Recent News
BioWorld Financial Watch
2026-01-15
Company data provided by crunchbase